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Abstract: Two new neolignans, manneoinsigins A (1) and B (2), together with four known lignans, were isolated from the leaves 
and stems of Manglietia insignis. The new compounds were established on the basis of extensive spectroscopic analyses. All  
compounds except 2 were tested for their cytotoxic activity. Compound 3 showed weak cytotoxic activity against the HL-60 human 
tumor cell line with the IC50 value of 23.5 μM. 
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Introduction 
Plants of the family Magnoliaceae are mainly distributed in 
southeastern Asia, which contain more than 250 species and 
are a rich source of lignans possessing various pharmacological
functions.1–9 Structural and biological diversity of lignans in 
magnoliaceae family prompted us to investigate Magnolia 
insignis Rehd. et Wils, a plant widely distributed in the west of 
China and being partly used as a substitute of M. officinalis in 
Yunnan and Sichuan provinces of China.4,10 As a result, two 
new neolignans, manneoinsigins A (1) and B (2), together with 
other four known lignans, scaphopetalone (3),11 meso-
secoisolariciresinol (4),12 lariciresinol (5)13 and evafolin B 
(6),14 were isolated. Herein, the isolation, structural elucidation, 
and their cytotoxic activity are described. 
 
Results and Discussion 
Manneoinsigin A (1) was obtained as yellow gum. The  
negative ESIMS of 1 showed characteristic peaks for [M – H]– 
and [M – H + 2]– with the ratio being 3:1, which suggested the 
presence of a chlorine atom. The molecular formula of 1 was 
determined as C18H19O4Cl by its HRESIMS with a  
pseudomolecular ion peak at m/z 333.0897 [M – H]–,  
corresponding to nine unsaturation degrees. The 1H NMR 
spectrum displayed signals due to two sets of ABX-type  
aromatic systems (H 7.28, 6.91 and 7.24; H 7.08, 6.84 and 
7.02), one terminal double bond (H 5.00, 5.05 and 5.97), two 
methylenes (H 3.33 and 3.61), and two methines (H 4.67 and 
3.85) (Table 1). The 13C NMR (DEPT) spectrum exhibited 
eighteen carbon signals, consisting of fourteen sp2 ones (two 
of which were signals of allyl group at C 115.6 and 139.4), 
two methylenes, and two oxygenated methines (Table 1). 
Comparison of 1D NMR spectra of 1 with those of magnolol 
showed that they possessed the same skeleton.15 The  
differences could be rationalized to be that the allyl group in 
magnolol was replaced by a 1,2-dihydroxy-3-chlorine-propyl 
group in 1. This was further supported by the HMBC  
correlations of H-7 (δH 4.67, 1H, d, J = 5.9 Hz) with C-1 (δC 
134.2), C-2 (δC 131.3), C-6 (δC 128.2), C-8 (δC 76.9) and C-9 
(δC 47.3), together with the 1H-1H COSY correlations of  
H-7/H-8/H2-9 (Fig. 2). Furthermore, the HMBC correlations of 
H-7 with C-1, C-2 and C-6 indicated that the 1,2-dihydroxy-3-
chlorine-propyl group was located at C-1 (Fig. 2). The  
chlorine atom was deduced to be located at C-9 by the  
characteristic chemical shift of C-9 at δC 47.3. 
 
Figure 1.  The structures of compounds 1–6 
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Manneoinsigin B (2) was obtained as yellow gum. The 
presence of a chlorine atom was deduced by the characteristic 
peaks for [M – H]– and [M – H + 2]– with the ratio being 3:1 
in its negative ESIMS. The molecular formula of 2 was  
deduced as C18H19O4Cl from its HREIMS (m/z 334.0964 [M]+). 
Detailed analysis of the 1D NMR data of 1 and 2 suggested 
that both of them had the same plane structure (Table 1). It 
was found that the differences of the 1H NMR chemical shifts 
of H-7 and H-9 from δH 4.67, 3.61, and 3.33 in 1 changing to δH 4.56, 3.77, and 3.67 in 2 and the 13C NMR chemical shifts 
of C-7, C-8 and C-9 from δC 75.4, 76.9, and 47.3 in 1  
changing to δC 75.8, 76.5, and 48.1. The reason for the minor 
distinct NMR data of 1 and 2 could be rationalized to the  
dissimilar configurations of the stereogenic carbons of the side 
chains. 
The OH configurations of two stereogenic centers in 1 and 2 
were determined by comparison with the 13C NMR data of the 
structural similar compounds, erythro- and threo-honokitriol16 
and erythro- and threo-1-C-syringylglycerol.17 The difference 
of 13C NMR chemical shifts of C-7 (δC 76.0) and C-8 (δC 76.2) 
in erythro-honokitriol is ᇞδC-8–C-7 0.2, which is smaller than 
that in threo-honokitriol (ᇞδC-8(77.8)–C-7(74.6) 3.2).16 In addition, 
the difference of 13C NMR chemical shifts of C-7 (δC 74.1) 
and C-8 (δC 75.3) in erythro-1-C-syringylglycerol is ᇞδC-8–C-7 
1.2, which is also smaller than that in its threo-isomer (ᇞδC-
8(75.8)–C-7(72.9) 2.9).17 Therefore，the relative configurations of 1 
and 2 could also be determined base on the rules as mentioned 
in the above cases.16,17 In compound 2, the difference of the 
carbon signals of C-7 (δC 75.8) and C-8 (δC 76.5) is ᇞδC-8–C-7 
0.7, which is smaller than that in 1 (ᇞδC-8(76.9)–C-7(75.4) 1.5). Thus, 
the structures of 1 and 2 were determined as threo- and 
erythro- configurations, respectively. As for the absolute  
configuration of C-7 and C-8, there should be four possibilities, 
i.e. (7R, 8R), (7R, 8S), (7S, 8R), and (7S, 8S). In the literature, 
four stereoisomers of 1-phenylglycidol with (1R, 2R), (1R, 2S), 
(1S, 2R), (1S, 2S) configurations were synthesized by an 
asymmetric method, and the optical data were [α]18D   – 45.5 (c 
3.3), [α]25D   – 38.5 (c 2.2), [α]20D   + 37.2 (c 3.4), [α]21D   + 45.0 (c 
2.4), respectively.18 By comparison of their optical data with 
those of threo isomer (1, [α]23.5D   – 11.0) and erythro isomer (2, 
[α]20D   – 14.6), it was confirmed that the configuration of C-7 
and C-8 in 1 and 2 were (7R, 8R) and (7R, 8S), respectively. 
Some chemical constituents from the Magnoliaceae family 
were reported to have obvious cytotoxic activities.1,9 Therefore, 
all compounds except compound 2 were assayed for their  
cytotoxicity against the HL-60, SMMC-7721, A-549, MCF-7, 
and SW-480 human tumor cell lines by the MTT method with 
cis-platin as positive control.19 Compound 3 showed weak 
cytotoxic activity against the HL-60 human tumor cell lines 
with the IC50 values of 23.5 μM. The other compounds did not 
show cytotoxic activity (IC50  > 40 μM). 
 
Experimental Section 
General Experimental Procedures. Optical rotations were 
measured with a JASCO DIP-370 digital polarimeter. UV 
spectra were obtained using a Shimadzu UV-2401A spectro-
photometer. A BioRad FtS-135 spectrophotometer was used 
for scanning IR spectroscopy with KBr pellets. 1D and 2D 
NMR spectra were recorded on Bruker AM-400, DRX-500 
and Bruker Avance III-600MHz spectrometers. Unless other-
wise specified, chemical shifts () were expressed in ppm with 
reference to the solvent signals. High resolution electrospray 
ionization (HRESIMS) were performed on a VG Autospec-
3000 spectrometer under 70 eV. Column chromatography was 
performed using silica gel (200–300 mesh, Qingdao Marine 
Chemical, Inc., Qingdao, China). Semi-preparative HPLC was 
performed on an Agilent 1100 liquid chromatograph with a 
Zorbax SB-C18, 9.4 mm  25 cm, column. Preparative HPLC 
was performed on a Shimadzu LC-8A preparative liquid 
chromatograph with a Shimadzu PRC-ODS (K) column.  
Table 1. 1H and 13C NMR spectroscopic assignments of compounds 1 and 2a 
 
position 
1  2 
δＨb δＣc δＨb δＣc 
1  134.2 s  134.0 s 
2 7.28 (d, 2.0) 131.3 d 7.30 (s) 131.6 d 
3  127.7 s  128.4 s 
4  155.2 s  156.5 s 
5 6.91 (d, 8.3) 117.4 d 6.88 (d, 8.2) 117.9 d 
6 7.24 (dd, 8.3, 2.0) 128.2 d 7.22 (d, 8.2) 128.7 d 
7 4.67 (d, 5.9) 75.4 d 4.56 (d, 6.8)  75.8 d 
8 3.85 (m) 76.9 d 3.88 (m)  76.5 d 
9 3.61 (dd, 11.4, 4.0); 3.33 (overlap) 47.3 t 3.77 (dd, 11.2, 2.7); 3.67 (dd, 11.2, 6.7) 48.1 t
1'  133.0 s  132.6 s 
2' 7.08 (d, 2.0) 132.7 d 7.13 (s) 132.6 d 
3'  127.6 s  128.2 s 
4'  153.6 s  154.7 s 
5' 6.84 (d, 8.2) 117.4 d 6.82 (d, 8.1) 118.0 d 
6' 7.02 (dd, 8.2, 2.0) 129.8 d 7.00 (d, 8.1) 129.8 d 
7' 3.36 (overlap) 40.4 t 3.34 (overlap) 40.7 d 
8' 5.97 (m) 139.4 d 5.98 (m) 139.8 d 
9' 5.05 (dd, 17.0, 1.6); 5.00 (dd, 10.2, 1.6) 115.6 t 5.05 (br. d, 17.0); 5.00 (br. d, 9.9) 115.6 t 






HMBCH1-H1 COSY  
Figure 2.  Selected 2D NMR correlations of 1 
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Fractions were monitored by TLC and spots were visualized 
by heating the silica gel plates sprayed with 10% H2SO4 in 
EtOH. 
 
Plant Materal. The leaves and stems of M. insignis (Wall.) 
Bl. was collected in Kunming Botanic Garden, Yunnan  
Province, China, in August 2007. The specimen was identified 
by Prof. Xun GONG and a voucher specimen (No. KIB 2007-
08-11) has been deposited at the State Key Laboratory of  
Phytochemistry and Plant Resources in West China, Kunming 
Institute of Botany, Chinese Academy of Sciences. 
 
Extraction and Isolation. The air-dried plant material of M. 
insignis (6.5 kg) was ground and exhaustively percolated three 
times with 70% aqueous Me2CO at room temperature. The 
solvent was evaporated in vacuo, and the combined crude  
extract was dissolved in H2O and partitioned with EtOAc. The 
EtOAc portion (156 g) was subsequently chromatographed on 
a silica gel column eluting with CHCl3-Me2CO (1:0, 9:1, 8:2, 
2:1, 1:1, and 0:1) and was combined into six groups (A–F) 
according to TCL analysis. Fraction B (21g) was chromato-
graphed on MPLC eluting with MeOH/H2O (30:70–100:0 
gradient system), to give fraction B1–B5. And then fraction 
B3 was further applied to silica gel CC, and eluted with  
petroleum ether-acetone (20:1, 12:1, 8:1 and 3:1) to give five 
fractions B3-1–B3-5. Compounds 1 (7.0 mg, tR = 29 min) and 
2 (2.1 mg, tR = 32 min) were obtained from fraction B3-2 by 
semi-preparative HPLC (42% aq. acetonitrile, 3 mL/min). 
Fraction B3-3 was chromatographed on Sephadex LH-20 
(MeOH) and then successively chromatographed on silica gel 
CC (CHCl3-ethyl acetate, 25:1, 16:1, 12:1 and 6:1) to give 
compound 6 (12 mg). Fraction B4 was further purified on  
silica gel CC (CHCl3-ethyl acetate, 24:1–8:1) and then  
chromatographed on Sephadex LH-20 (MeOH) to give six 
fractions B4-1–B4-6. Fraction B4-2 were further subjected to 
semi-preparative HPLC (53% aq. MeOH, 3 mL/min) to afford 
3 (9.0 mg, tR = 18 min) and 4 (14.6 mg, tR = 24 min).  
Compound 5 (5.6 mg, tR = 18 min) were purified by semi-
preparative HPLC (55% aq. MeOH, 3 mL/min) from fraction 
B4-3. 
 
Manneoinsigin A (1): yellow gum; [α]23.5D   – 11.0 (c 0.23, 
MeOH); UV (MeOH) max (log ) 289 (3.27), 214 (4.01), 191 
(3.76) nm; IR (KBr) max 3424, 3081, 2924, 2853, 1639, 1619, 
1496, 1423, 1230, 915, 826 cm–1; 1H and 13C NMR data, see 
Table 1; negative ESIMS m/z 333 [M – H]– and isotopic peak 
m/z 335 [M – H]–; negative HRESIMS m/z 333.0897 [M – H]–  
(calcd for C18H18O4Cl, 333.0893) and isotopic peak m/z 
335.0908 [M – H]– (calcd for C18H18O4Cl, 335.0864). 
 
Manneoinsigin B (2): yellow gum; [α]23.5D   – 14.6 (c 0.11, 
MeOH); UV (MeOH) max (log ) 289 (3.49), 212 (4.20), 196 
(3.84) nm; IR (KBr) max 3426, 3080, 2927, 2856, 1638, 1624, 
1496, 1230, 917, 830 cm–1; 1H and 13C NMR data, see Table 1; 
negative ESIMS m/z 333 [M – H]– and isotopic peak m/z 335 
[M – H]–; HREIMS m/z 334.0964 [M]+ (calcd for C18H19O4Cl, 
334.0972) and isotopic peak m/z 336.0961 [M]+ (calcd for 
C18H19O4Cl, 336.0942). 
 
Cytotoxicity Assay. The following human tumor cell lines 
were used: HL-60, MMC-7721, A549, MCF-7, and SW480. 
All cells were cultured in RPMI-1640 or DMEM medium 
(Hyclone, Logan, UT), supplemented with 10% fetal bovine 
serum (Hyclone) at 37 oC in a humidified atmosphere with 5% 
CO2. Cell viability was assessed by conducting colorimetric 
measurements of the amount of insoluble formazan formed in 
living cells based on the reduction of 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma, St. Louis, 
MO).19 Briefly, 100 μL of adherent cells was seeded into each 
well of a 96-well cell culture plate and allowed to adhere for 
12 h before drug addition, while suspended cells were seeded 
just before drug addition, both with an initial density of 1×105 
cells/mL in 100 μL of medium. Each cell line was exposed to 
the test compound at various concentrations in triplicate for 48 
h, with cisplatin and paclitaxel (Sigma) as positive controls. 
After the incubation, MTT (100 μg) was added to each well, 
and the incubation continued for 4 h at 37 oC. The cells were 
lysed with 100 μL of 20% SDS-50% DMF after removal of 
100 μL of medium. The optical density of the lysate was 
measured at 595 nm in a 96-well microtiter plate reader (Bio-
Rad 680). The IC50 value of each compound was calculated by 
Reed and Muench’s method.20 
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